169 related articles for article (PubMed ID: 28681401)
1. Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort study.
von Podewils F; Suesse M; Geithner J; Gaida B; Wang ZI; Lange J; Dressel A; Grothe M; Kessler C; Langner S; Runge U; Bien CG
Epilepsia; 2017 Sep; 58(9):1542-1550. PubMed ID: 28681401
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.
Joubert B; Saint-Martin M; Noraz N; Picard G; Rogemond V; Ducray F; Desestret V; Psimaras D; Delattre JY; Antoine JC; Honnorat J
JAMA Neurol; 2016 Sep; 73(9):1115-24. PubMed ID: 27428927
[TBL] [Abstract][Full Text] [Related]
3. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients.
Elisak M; Krysl D; Hanzalova J; Volna K; Bien CG; Leypoldt F; Marusic P
Seizure; 2018 Dec; 63():1-6. PubMed ID: 30391660
[TBL] [Abstract][Full Text] [Related]
5. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic challenges in patients with temporal lobe seizures and features of autoimmune limbic encephalitis.
Ismail FS; Spatola M; Woermann FG; Popkirov S; Jungilligens J; Bien CG; Wellmer J; Schlegel U
Eur J Neurol; 2022 May; 29(5):1303-1310. PubMed ID: 34288284
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
Boyko M; Au KLK; Casault C; de Robles P; Pfeffer G
J Neurol; 2020 Apr; 267(4):1137-1146. PubMed ID: 31912210
[TBL] [Abstract][Full Text] [Related]
8. Predictive models in the diagnosis and treatment of autoimmune epilepsy.
Dubey D; Singh J; Britton JW; Pittock SJ; Flanagan EP; Lennon VA; Tillema JM; Wirrell E; Shin C; So E; Cascino GD; Wingerchuk DM; Hoerth MT; Shih JJ; Nickels KC; McKeon A
Epilepsia; 2017 Jul; 58(7):1181-1189. PubMed ID: 28555833
[TBL] [Abstract][Full Text] [Related]
9. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
10. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
11. Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma.
Lee CH; Lin JJ; Lin KJ; Chang BL; Hsieh HY; Chen WH; Lin KL; Fung HC; Wu T
J Neurol Sci; 2014 Jun; 341(1-2):36-40. PubMed ID: 24726720
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Encephalitis in Late-Onset Seizures: When to Suspect and How to Treat.
Süße M; Zank M; von Podewils V; von Podewils F
Front Neurol; 2021; 12():633999. PubMed ID: 33897594
[No Abstract] [Full Text] [Related]
13. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
[TBL] [Abstract][Full Text] [Related]
14. Anti-Neuronal Autoantibodies in Both Drug Responsive and Resistant Focal Seizures with Unknown Cause.
Gozubatik-Celik G; Ozkara C; Ulusoy C; Gunduz A; Delil S; Yeni N; Tuzun E
Epilepsy Res; 2017 Sep; 135():131-136. PubMed ID: 28675819
[TBL] [Abstract][Full Text] [Related]
15. Circulating neural antibodies in unselected children with new-onset seizures.
Garcia-Tarodo S; Datta AN; Ramelli GP; Maréchal-Rouiller F; Bien CG; Korff CM
Eur J Paediatr Neurol; 2018 May; 22(3):396-403. PubMed ID: 29291919
[TBL] [Abstract][Full Text] [Related]
16. Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report.
Cianci V; Labate A; Lanza P; Vincent A; Gambardella A; Branca D; Arcudi L; Aguglia U
Seizure; 2010 Sep; 19(7):446-9. PubMed ID: 20598587
[TBL] [Abstract][Full Text] [Related]
17. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
18. Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis.
Benoit J; Muñiz-Castrillo S; Vogrig A; Farina A; Pinto AL; Picard G; Rogemond V; Guery D; Alentorn A; Psimaras D; Rheims S; Honnorat J; Joubert B
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36288995
[TBL] [Abstract][Full Text] [Related]
19. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
20. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.
Gadoth A; Pittock SJ; Dubey D; McKeon A; Britton JW; Schmeling JE; Smith A; Kotsenas AL; Watson RE; Lachance DH; Flanagan EP; Lennon VA; Klein CJ
Ann Neurol; 2017 Jul; 82(1):79-92. PubMed ID: 28628235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
